PRME
Income statement / Annual
Last year (2023), Prime Medicine, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Prime Medicine, Inc.'s net income was -$198.13 M.
See Prime Medicine, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$5.21 M
|
$0.00
|
| Cost of Revenue |
$147.91 M |
$0.00 |
$0.00 |
$0.00 |
$2.76 M |
| Gross Profit |
-$147.91 M |
$0.00 |
$0.00 |
$0.00 |
-$2.76 M |
| Gross Profit Ratio |
0 |
-1.31 |
0 |
0 |
0 |
| Research and Development
Expenses |
$147.91 M
|
$86.73 M
|
$70.55 M
|
$2.98 M
|
$920,000.00
|
| General & Administrative
Expenses |
$43.39 M
|
$29.82 M
|
$13.92 M
|
$3.16 M
|
$3.76 M
|
| Selling & Marketing
Expenses |
-$4.65 M
|
$0.00
|
$0.00
|
$0.00
|
$1.25 M
|
| Selling, General &
Administrative Expenses |
$38.73 M
|
$29.82 M
|
$13.92 M
|
$3.16 M
|
$1.25 M
|
| Other Expenses |
$0.00 |
$1.90 M |
-$80.99 M |
-$11.48 M |
$0.00 |
| Operating Expenses |
$186.64 M |
$116.54 M |
$84.47 M |
$6.14 M |
$2.17 M |
| Cost And Expenses |
$191.29 M |
$116.54 M |
$84.47 M |
$6.14 M |
$2.17 M |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$12.13 M |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$4.65 M
|
$12.01 M
|
$4.86 M
|
$43,000.00
|
$6.52 M
|
| EBITDA |
-$193.76 M
|
-$110.76 M
|
-$160.99 M
|
-$889,000.00
|
-$2.17 M
|
| EBITDA Ratio |
0 |
-20.81 |
0 |
-2.26 |
0 |
| Operating Income Ratio
|
0
|
-22.37
|
0
|
-0.18
|
0
|
| Total Other
Income/Expenses Net |
-$7.12 M
|
-$6.23 M
|
-$81.38 M
|
-$611,000.00
|
$3.99 M
|
| Income Before Tax |
-$198.41 M |
-$122.77 M |
-$165.85 M |
-$1.54 M |
-$2.53 M |
| Income Before Tax Ratio
|
0
|
-23.56
|
0
|
-0.3
|
0
|
| Income Tax Expense |
-$279,000.00 |
-$948,000.00 |
-$486,000.00 |
$1.87 M |
$4,000.00 |
| Net Income |
-$198.13 M |
-$121.82 M |
-$165.37 M |
-$3.41 M |
-$2.53 M |
| Net Income Ratio |
0 |
-23.38 |
0 |
-0.65 |
0 |
| EPS |
-2.18 |
-1.25 |
-2.55 |
-0.0704 |
-0.0264 |
| EPS Diluted |
-2.18 |
-1.25 |
-2.55 |
-0.0704 |
-0.0264 |
| Weighted Average Shares
Out |
$90.97 M
|
$97.21 M
|
$64.90 M
|
$71.80 M
|
$95.73 M
|
| Weighted Average Shares
Out Diluted |
$90.97 M
|
$97.21 M
|
$64.90 M
|
$71.80 M
|
$95.73 M
|
| Link |
|
|
|
|
|
